HPV and coronary diseases in menopausal women: an integrative review.

High-risk human papillomavirus (HPV) infection is associated with cervical cancer while low-risk HPV strains mostly cause benign lesions. Multiple studies have also associated HPV with coronary artery (CAD) disease in women. Furthermore, the climacteric period in women, triggers chronic inflammation and has major implications for CAD and associated lipid disorders. The association of HPV with coronary artery disease in climacteric women has few studies, and the objective of this review is to gather and analyse scientific data on the subject. This is an integrative review performed on PubMed and Google Scholar using the keywords "HPV", "coronary heart disease" and "climacteric", among these keywords the boolean operator AND and the publication date filter. (2018 onwards). Five articles were found, whose main results show presence of high-risk vaginal HPV in climacteric women. Climacterium and HPV were associated with a three-fold increased risk of CAD, as well as with factors related to menopause that promote atheroma formation, lipid disorders and chronic inflammation. Thus, these results support the association between HPV infection and CAD in climacteric women, possibly via chronic inflammation, hormonal factors related to menopause and dyslipidemia.

Effects of Different Exercise Interventions on Cardiorespiratory Fitness, as Measured by Peak Oxygen Consumption in Patients with Coronary Heart Disease: An Overview of Systematic Reviews.

BACKGROUND: Exercise is an important component of rehabilitation care for people with coronary heart disease (CHD). OBJECTIVES: The aim of this study was to critically analyze and summarize the existing evidence from published systematic reviews (SRs) and meta-analyses of randomized controlled trials (RCTs) that have evaluated the effects of different types of exercise interventions on cardiorespiratory fitness, as measured by peak oxygen consumption in people with CHD. METHODS: Electronic databases (Cochrane Library, Medline/PubMed, EMBASE, and PEDro) were searched for SRs of exercise interventions of people with CHD. Two reviewers assessed the quality of SRs using the AMSTAR-2 tool and evaluated the strength of evidence quality with the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system for relevant outcome measures. Mean difference (MD) and 95% confidence intervals (CIs) were calculated. RESULTS: Thirty-one SRs (with 125 RCTs) met the study criteria, including 33,608 patients. Compared with usual care, continuous aerobic exercise produced an improvement in peak oxygen consumption, MD of 3.8 mL kg-1 min-1 (95% CI: 3.204.4, I2 = 67%); high-intensity interval training, MD 6.1 mL kg-1 min-1 (95% CI: 0.4-11.8, I2 = 97%); resistance training, MD of 2.1 mL kg-1 min-1 (95% CI: 0.98-3.2, I2 = 60%); combined aerobic and resistance training, MD of 3.0 mL kg-1 min-1 (95% CI: 2.5-3.4, I2 = 0%); and water-based exercise, MD of 4.4 mL kg-1 min-1 (95% CI, 2.1-6.7; I2 = 2%). CONCLUSION: Exercise interventions improve peak oxygen consumption in people with CHD. However, there was moderate to very-low certainty for the evidence found.

The burden of premature coronary heart disease among adults with low socioeconomic status in Argentina: A modeling study.

BACKGROUND: The well-established inverse relationship between socioeconomic status (SES) and risk of developing coronary heart disease (CHD) cannot be explained solely by differences in traditional risk factors. OBJECTIVE: To model the role SES plays in the burden of premature CHD in Argentina. MATERIALS AND METHODS: We used the Cardiovascular Disease Policy Model-Argentina to project incident CHD events and mortality in low and high-SES Argentinean adults 35 to 64 years of age from 2015 to 2024. Using data from the 2018 National Risk Factor Survey, we defined low SES as not finishing high-school and/or reporting a household income in quintiles 1 or 2. We designed simulations to apportion CHD outcomes in low SES adults to: (1) differences in the prevalence of traditional risk factors between low and high SES adults; (2) nontraditional risk associated with low SES status; (3) preventable events if risk factors were improved to ideal levels; and (4) underlying age- and sex-based risk. RESULTS: 56% of Argentina´s 35- to 64-year-old population has low SES. Both high and low SES groups have poor control of traditional risk factors. Compared with high SES population, low SES population had nearly 2-fold higher rates of incident CHD and CHD deaths per 10 000 person-years (incident CHD: men 80.8 [95%CI 76.6-84.9] vs 42.9 [95%CI 37.4-48.1], women 39.0 [95%CI 36.-41.2] vs 18.6 [95%CI 16.3-20.9]; CHD deaths: men 10.0 [95%CI 9.5-10.5] vs 6.0 [95%CI 5.6-6.4], women 3.2 [95%CI 3.0-3.4] vs 1.8 [95%CI 1.7-1.9]). Nontraditional low SES risk accounts for 73.5% and 70.4% of the event rate gap between SES levels for incident CHD and CHD mortality rates, respectively. DISCUSSION: CHD prevention policies in Argentina should address contextual aspects linked to SES, such as access to education or healthcare, and should also aim to implement known clinical strategies to achieve better control of CHD risk factors in all socioeconomic levels.

Empagliflozin's role in reducing ventricular repolarization heterogeneity: insights into cardiovascular mortality decline from the EMPATHY-HEART trial.

BACKGROUND: The incidence of myocardial infarction (MI) and sudden cardiac death (SCD) is significantly higher in individuals with Type 2 Diabetes Mellitus (T2DM) than in the general population. Strategies for the prevention of fatal arrhythmias are often insufficient, highlighting the need for additional non-invasive diagnostic tools. The T-wave heterogeneity (TWH) index measures variations in ventricular repolarization and has emerged as a promising predictor for severe ventricular arrhythmias. Although the EMPA-REG trial reported reduced cardiovascular mortality with empagliflozin, the underlying mechanisms remain unclear. This study investigates the potential of empagliflozin in mitigating cardiac electrical instability in patients with T2DM and coronary heart disease (CHD) by examining changes in TWH. METHODS: Participants were adult outpatients with T2DM and CHD who exhibited TWH > 80 µV at baseline. They received a 25 mg daily dose of empagliflozin and were evaluated clinically including electrocardiogram (ECG) measurements at baseline and after 4 weeks. TWH was computed from leads V4, V5, and V6 using a validated technique. The primary study outcome was a significant (p < 0.05) change in TWH following empagliflozin administration. RESULTS: An initial review of 6,000 medical records pinpointed 800 patients for TWH evaluation. Of these, 412 exhibited TWH above 80 µV, with 97 completing clinical assessments and 90 meeting the criteria for high cardiovascular risk enrollment. Empagliflozin adherence exceeded 80%, resulting in notable reductions in blood pressure without affecting heart rate. Side effects were generally mild, with 13.3% experiencing Level 1 hypoglycemia, alongside infrequent urinary and genital infections. The treatment consistently reduced mean TWH from 116 to 103 µV (p = 0.01). CONCLUSIONS: The EMPATHY-HEART trial preliminarily suggests that empagliflozin decreases heterogeneity in ventricular repolarization among patients with T2DM and CHD. This reduction in TWH may provide insight into the mechanism behind the decreased cardiovascular mortality observed in previous trials, potentially offering a therapeutic pathway to mitigate the risk of severe arrhythmias in this population. TRIAL REGISTRATION: NCT: 04117763.

Effects of aerobic exercise on myocardial injury, NF-B expression, glucolipid metabolism and inflammatory factors in rats with coronary heart disease.

OBJECTIVE: To investigate the influence of aerobic exercise on myocardial injury, NF-B expression, glucolipid metabolism and inflammatory factors in rats with Coronary Heart Disease (CHD) and explore the possible causative role. METHODS: 45 Sprague Dawley® rats were randomized into model, control and experimental groups. A high-fat diet was adopted for generating a rat CHD model, and the experimental group was given a 4-week aerobic exercise intervention. ECG was utilized to evaluate the cardiac function of the rats; HE staining to evaluate the damage of myocardial tissue; TUNEL staining to evaluate cardiomyocyte apoptosis level; ELISA to assay the contents of inflammatory factors and glucolipid metabolism in cardiomyocytes; qPCR to assay IB- and NF-B mRNA expression; Western-blot to assay the apoptosis-related proteins and NF-B signaling pathway-related proteins expressions in myocardial tissue. RESULTS: In contrast to the model group, aerobic exercise strongly improved the rat's cardiac function and glucolipid metabolism (p < 0.01), enhanced IL-10 content, Bcl-2/Bax level as well as IB- protein and mRNA expression (p < 0.01), and reduced myocardial injury and cardiomyocyte apoptosis, the contents of IL-6, IL-1 and TNF-, Caspase 3 level, NF-B mRNA and protein expression and p-p38 and p-STAT3 expressions (p < 0.01). CONCLUSION: Aerobic exercise can not only effectively reduce myocardial injury, the release of inflammatory factors and NF-B expression in CHD rats, but also improve cardiac function and glucolipid metabolism. Its mechanism is likely to be related to the inhibition of the NF-B signaling pathway.

The Effectiveness of Telemedicine in the Management of Chronic Diseases (Diabetes, Hypertension, and Coronary Heart Disease) at Primary Care Facilities in Eastern Trinidad During the COVID-19 Pandemic.

Introduction: During the COVID-19 pandemic, Trinidad and Tobago's government implemented lockdowns and limited the availability of outpatient clinics to curb virus transmission. Subsequently, telemedicine via telephone calls was utilized to address infection control and continuity of care for chronic disease patients. Methods: An observational study was conducted at three primary care facilities in Eastern Trinidad using convenience sampling to review retrospectively telemedicine patients' medical records from October 2019 to February 2020 (before telemedicine) and from March 2020 to September 2020 (during telemedicine) for comparative analysis. Data were analyzed using IBM SPSS Statistics 28.0 software and Microsoft Excel. Results: A total of 199 patient files were analyzed; 57.3% of these were female; 52.3% were 60 years and older. A Wilcoxon signed-rank test demonstrated no statistically significant differences between random blood sugar (RBS) readings (0.355), weight (0.621), or systolic and diastolic blood pressure (BP; 0.239 and 0.232, respectively) before and during the 6-month period of telemedicine consultation. Patients compliant with medication before the use of telemedicine were 14 times more likely to attain target BPs. There was no significant association between compliance with prescribed therapy and BP control (0.335) during the period of telemedicine. Discussion: The findings support the use of telemedicine to manage chronic diseases such as hypertension, diabetes mellitus, and coronary heart disease, as the standard of care was preserved, and no inferiority of recorded outcomes was demonstrated. Although there was an overall decrease in compliance during the telemedicine period compared with before, comparative analysis exhibited no statistically significant differences in BP or RBS readings.

Adaptação cultural e validação do instrumento Acute Coronary Syndrome Response Index para uso no Brasil / Cultural adaptation and validation of the Acute Coronary Syndrome Response Index for use in Brazil

As doenças cardiovasculares, com destaque para a síndrome coronariana aguda (SCA), representam a principal causa de mortalidade mundial. Essa síndrome é a manifestação clínica mais comum da doença arterial coronariana (DAC). O intervalo de tempo entre o início dos sintomas e a reperfusão do miocárdio é crucial para a sobrevivência dos pacientes. Contudo, a falta de conhecimento e a demora para reconhecer os sintomas isquêmicos são os principais fatores que influenciam no atraso do atendimento pré-hospitalar. Programas educativos e instrumentos de avaliação são importantes estratégias para educar a população e reduzir eventos recorrentes da SCA. Nossa revisão de literatura demonstrou que, no Brasil, não dispomos de um instrumento validado para avaliar o conhecimento dos indivíduos sobre esta síndrome. O Acute Coronary Syndrome (ACS) Response Index avalia a resposta do indivíduo à SCA, por meio de seu conhecimento, atitudes e crenças. Dessa forma, o objetivo deste estudo metodológico foi adaptar culturalmente e verificar as propriedades de medida da versão adaptada para o Brasil do ACS Response Index, em pacientes com 18 anos ou mais, de ambos os sexos e diagnosticados com DAC. O processo de adaptação cultural transcorreu de acordo com as seguintes etapas: tradução inicial; obtenção do consenso das versões em português; comitê de especialistas; retrotradução; obtenção do consenso das versões em inglês; avaliação pelo autor da versão original; análise semântica; e pré-teste. As seguintes propriedades de medida foram avaliadas: consistência interna, validade de face e de conteúdo, validade de construto entre grupos conhecidos, validade de constructo convergente, validade estrutural e presença de efeitos teto e chão. O nível de significância adotado foi de 0,05. Participaram do estudo 244 indivíduos com DAC. As pontuações médias para as subescalas de conhecimento, atitudes e crenças foram, respectivamente: 12,75 (DP=2,6), 13,48 (DP=3,39) e 22,40 (DP=3,16). A consistência interna da subescala de conhecimento foi avaliada pelo KR-20, cujo valor foi de 0,399. Os resultados dos alfas de Cronbach para as subescalas de atitudes e de crenças foram 0,735 e 0,577, respectivamente. A estrutura original do instrumento foi testada mediante análise fatorial confirmatória, para a qual obteve-se índices de ajuste satisfatórios para as subescalas de conhecimento (SRMR=0,065; RMSEA=0,058; CFI=0,792; TLI=0,761), atitudes (SRMR=0,027; RMSEA=0,053; CFI=0,988; TLI=0,970) e crenças (SRMR=0,047; RMSEA=0,048; CFI=0,971; TLI=0,952). As hipóteses prévias sobre a validade de constructo por grupos conhecidos foram testadas para comparar os valores das três subescalas segundo a faixa etária, presença de orientação prévia sobre sua doença cardíaca e nível escolaridade. Apenas as seguintes hipóteses foram confirmadas: na subescala de conhecimento, os indivíduos com até 59 anos apresentaram melhores níveis de conhecimento quando comparados aos indivíduos com 60 anos ou mais (p=0,003); na subescala de crenças, maiores valores foram obtidos no grupo que relatou orientação prévia sobre sua doença (p=0,008) e naqueles com maior escolaridade (p=0,022). A avaliação da validade de constructo convergente mostrou correlação fraca e positiva entre as subescalas de conhecimento e crenças (r=0,217; p<0,05), e de conhecimento e atitudes (r=0,128; p<0,05). Não encontramos correlação entre os valores das demais subescalas. Constatamos a presença do efeito teto em todos os itens das subescalas de atitudes e de crenças. Os resultados mostraram que o ACS Response Index-BR manteve as equivalências, validade de face e de conteúdo, validade de constructo entre grupos conhecidos nas subescalas de conhecimentos e crenças, ajuste adequado ao modelo estrutural original e confiabilidade satisfatória para a subescala de atitudes. Entretanto, dadas as particularidades da amostra, sugerimos a realização de estudos adicion

As doenças cardiovasculares, com destaque para a síndrome coronariana aguda (SCA), representam a principal causa de mortalidade mundial. Essa síndrome é a manifestação clínica mais comum da doença arterial coronariana (DAC). O intervalo de tempo entre o início dos sintomas e a reperfusão do miocárdio é crucial para a sobrevivência dos pacientes. Contudo, a falta de conhecimento e a demora para reconhecer os sintomas isquêmicos são os principais fatores que influenciam no atraso do atendimento pré-hospitalar. Programas educativos e instrumentos de avaliação são importantes estratégias para educar a população e reduzir eventos recorrentes da SCA. Nossa revisão de literatura demonstrou que, no Brasil, não dispomos de um instrumento validado para avaliar o conhecimento dos indivíduos sobre esta síndrome. O Acute Coronary Syndrome (ACS) Response Index avalia a resposta do indivíduo à SCA, por meio de seu conhecimento, atitudes e crenças. Dessa forma, o objetivo deste estudo metodológico foi adaptar culturalmente e verificar as propriedades de medida da versão adaptada para o Brasil do ACS Response Index, em pacientes com 18 anos ou mais, de ambos os sexos e diagnosticados com DAC. O processo de adaptação cultural transcorreu de acordo com as seguintes etapas: tradução inicial; obtenção do consenso das versões em português; comitê de especialistas; retrotradução; obtenção do consenso das versões em inglês; avaliação pelo autor da versão original; análise semântica; e pré-teste. As seguintes propriedades de medida foram avaliadas: consistência interna, validade de face e de conteúdo, validade de construto entre grupos conhecidos, validade de constructo convergente, validade estrutural e presença de efeitos teto e chão. O nível de significância adotado foi de 0,05. Participaram do estudo 244 indivíduos com DAC. As pontuações médias para as subescalas de conhecimento, atitudes e crenças foram, respectivamente: 12,75 (DP=2,6), 13,48 (DP=3,39) e 22,40 (DP=3,16). A consistência interna da subescala de conhecimento foi avaliada pelo KR-20, cujo valor foi de 0,399. Os resultados dos alfas de Cronbach para as subescalas de atitudes e de crenças foram 0,735 e 0,577, respectivamente. A estrutura original do instrumento foi testada mediante análise fatorial confirmatória, para a qual obteve-se índices de ajuste satisfatórios para as subescalas de conhecimento (SRMR=0,065; RMSEA=0,058; CFI=0,792; TLI=0,761), atitudes (SRMR=0,027; RMSEA=0,053; CFI=0,988; TLI=0,970) e crenças (SRMR=0,047; RMSEA=0,048; CFI=0,971; TLI=0,952). As hipóteses prévias sobre a validade de constructo por grupos conhecidos foram testadas para comparar os valores das três subescalas segundo a faixa etária, presença de orientação prévia sobre sua doença cardíaca e nível escolaridade. Apenas as seguintes hipóteses foram confirmadas: na subescala de conhecimento, os indivíduos com até 59 anos apresentaram melhores níveis de conhecimento quando comparados aos indivíduos com 60 anos ou mais (p=0,003); na subescala de crenças, maiores valores foram obtidos no grupo que relatou orientação prévia sobre sua doença (p=0,008) e naqueles com maior escolaridade (p=0,022). A avaliação da validade de constructo convergente mostrou correlação fraca e positiva entre as subescalas de conhecimento e crenças (r=0,217; p<0,05), e de conhecimento e atitudes (r=0,128; p<0,05). Não encontramos correlação entre os valores das demais subescalas. Constatamos a presença do efeito teto em todos os itens das subescalas de atitudes e de crenças. Os resultados mostraram que o ACS Response Index-BR manteve as equivalências, validade de face e de conteúdo, validade de constructo entre grupos conhecidos nas subescalas de conhecimentos e crenças, ajuste adequado ao modelo estrutural original e confiabilidade satisfatória para a subescala de atitudes. Entretanto, dadas as particularidades da amostra, sugerimos a realização de estudos adicion

Relationship between Increased Plasma Levels of Legumain and Properties of Coronary Atherosclerotic Plaque. / Relação entre Níveis Plasmáticos Aumentados de Legumain e Propriedades da Placa Aterosclerótica Coronária.

BACKGROUND: Many clinical studies have confirmed that legumain is closely related to atherosclerosis. Unfortunately, different conclusions have been reached, and analyses and studies on atherosclerotic plaque characteristics in patients with increased plasma levels of legumain are still lacking. OBJECTIVES: This study aimed to investigate the correlation between legumain and coronary atherosclerotic plaque characteristics. METHODS: A total of 81 patients with coronary atherosclerotic heart disease (CHD), including 43 patients with unstable angina (UA) and 38 patients with stable angina (SA), were screened by coronary angiography. Intravascular ultrasound (IVUS) was performed to evaluate the characteristics of coronary atherosclerotic plaques, and plasma legumain levels were also measured. Values of p < 0.05 were considered significant. RESULTS: Legumain concentration was significantly higher in the two CHD subgroups than in the control group (all p<0.001). Legumain concentrations in the UA group were significantly higher than in the SA group (p=0.001). The plaque area, remodeling index (RI), and eccentricity index (EI) in the UA group were significantly higher than those in the SA group (p<0.001, p=0.001, p=0.001, respectively). There was a significant positive correlation between legumain levels and RI and EI in both UA and SA patients (all p<0.05). CONCLUSIONS: High plasma levels of legumain were closely related to the occurrence and severity of CHD, and the lesions tended to be unstable. Legumain is expected to be a potential inflammatory biomarker for the diagnosis of CHD and the early identification of unstable coronary lesions.

FUNDAMENTO: Muitos estudos clínicos confirmaram que a legumain está intimamente relacionada à aterosclerose. Infelizmente, chegaram-se a conclusões diferentes e ainda faltam análises e estudos sobre as características da placa aterosclerótica em pacientes com níveis plasmáticos aumentados de legumain. OBJETIVOS: Este estudo teve como objetivo investigar a correlação entre as características da legumain e da placa aterosclerótica coronariana. MÉTODOS: Um total de 81 pacientes com doença cardíaca aterosclerótica coronariana (DCAC), incluindo 43 pacientes com angina instável (AI) e 38 pacientes com angina estável (AE), foram examinados por angiografia coronária. Foi realizado ultrassom intravascular (IVUS) para avaliar as características das placas ateroscleróticas coronarianas, e os níveis plasmáticos de legumain também foram medidos. Valores de p < 0,05 foram considerados significativos. RESULTADOS: A concentração de legumain foi significativamente maior nos dois subgrupos de doença coronariana do que no grupo controle (todos p<0,001). As concentrações de legumain no grupo AI foram significativamente maiores do que no grupo SA (p=0,001). A área de placa, o índice de remodelamento (IR) e o índice de excentricidade (IE) no grupo AI foram significativamente maiores do que no grupo AE (p<0,001, p=0,001, p=0,001, respectivamente). Houve uma correlação positiva significativa entre os níveis de legumain e IR e IE em pacientes com AI e AE (todos p<0,05). CONCLUSÕES: Níveis plasmáticos elevados de legumain estavam intimamente relacionados com a ocorrência e gravidade da doença coronariana, e as lesões tendiam a ser instáveis. Espera-se que a legumain seja um potencial biomarcador inflamatório para o diagnóstico de doença coronariana e a identificação precoce de lesões coronárias instáveis.

Impact of Educational Interventions to Foster Health in Patients Undergoing Cardiac Rehabilitation: A Systematic Review / Impacto de las intervenciones educativas para fomentar la salud en pacientes en rehabilitación cardiaca: revisión sistemática / Impacto das intervenções educativas para promover a saúde em pacientes de reabilitação cardíaca: uma revisão sistemática

Introduction: Cardiovascular diseases represent the leading cause of death worldwide, and education interventions are an effective measure to control modifiable risk factors in patients undergoing cardiac rehabilitation; therefore, studying this phenomenon allows expanding the tools to face this situation. Objective: To determine the impact of educational interventions to foster health in patients undergoing cardiac rehabilitation. Materials and methods: A scientific literature review was conducted in the PubMed, SciELO, LILACS, EBSCO, MEDES, CUIDEN, Dialnet, ScienceDirect and CUIDATGE databases, based on the PRISMA statement proposal for systematic reviews, registered in the Prospero database (CRD42023398444). The Jadad scale was used for the methodological assessment, according to the peer approach. Results: The initial search yielded 14,849 publications, with 10 of them meeting the inclusion criteria. The mean age of the sample population was 63 years old, male gender. Telemedicine and education software design were resources to implement the interventions, finding a reduction in hospitalizations for cardiac reasons. Regarding mental health, long-term reductions in anxiety and depression were found. Conclusions: The time until the first cardiovascular hospitalization was 502 (469-535) days in the Intervention Group, against 445 (400-491) days in the Control Group. When evaluating medication adherence, it was evidenced that 94 % of the participants had improvements. Regarding cardiovascular risk stratification, both the intervention (26 %) and the control (6 %) groups shifted to the lower-risk class.

Introducción: las enfermedades cardiovasculares representan la primera causa de muerte a nivel mundial, y las intervenciones educativas representan una medida eficaz para controlar factores de riesgo modificables en pacientes en rehabilitación cardiaca, por ello estudiar este fenómeno permite ampliar las herramientas frente a esta situación. Objetivo: determinar el impacto de las intervenciones educativas para fomentar la salud en pacientes en rehabilitación cardiaca. Materiales y métodos: se realizó una revisión de la literatura científica en las bases de datos Pudmed, Scielo, Lilacs, Ebsco, Medes, Cuiden, Dialnet, Science Direct y Cuidatge, basada en la propuesta de la declaración Prisma para revisiones sistemáticas, y se registró en la base Prospero (CRD42023398444). La escala Jadad se usó para la evaluación metodológica, bajo el enfoque de dos pares. Resultados: la búsqueda inicial arrojó 14 849 publicaciones, de las cuales al final 10 cumplieron los criterios de inclusión. La edad promedio de la población de la muestra fue 63 años, de sexo masculino. La telemedicina y el diseño de software para educación fueron recursos para implementar las intervenciones, encontrando disminución de las rehospitalizaciones por causas coronarias. Respecto a la salud mental, se encontró disminución de la ansiedad y depresión a largo plazo. Conclusiones: el tiempo hasta la primera rehospitalización cardiovascular fue de 502 (469-535) días en el grupo de intervención, frente a 445 (400-491) días en el grupo control. Al evaluar la adherencia a la medicación, se evidenció que el 94 % de los participantes tuvo mejoras. En cuanto a la estratificación del riesgo cardiovascular, tanto el grupo de intervención (26 %) como el grupo control (6 %) cambiaron a clase de menor riesgo.

Introdução: as doenças cardiovasculares são a principal causa de morte em todo o mundo, e as intervenções educativas representam uma medida eficaz no controle dos fatores de risco modificáveis em pacientes de reabilitação cardíaca, razão pela qual o estudo deste fenómeno permite ampliar as ferramentas perante esta situação. Objetivo: determinar o impacto das intervenções educativas na promoção da saúde em pacientes de reabilitação cardíaca. Materiais e métodos: foi realizada uma revisão da literatura científica nas bases de dados PubMed, SciELO, LILACS, EBSCO, MEDES, CUIDEN, Dialnet, ScienceDirect e CUIDATGE, baseada na proposta da declaração Prisma para revisões sistemáticas, sendo registrada na base Prospero (CRD42023398444). A escala Jadad foi utilizada para avaliação metodológica, sob a abordagem de dois pares. Resultados: a pesquisa inicial envolveu 14.849 publicações, das quais 10 cumpriram com os critérios de inclusão. A média de idade da população da amostra foi de 63 anos, do sexo masculino. Telemedicina e design de software educativo foram os recursos utilizados para implementar as intervenções, constatando-se uma diminuição nas rehospitalizações por causas coronárias. Em relação à saúde mental, verificou-se uma diminuição da ansiedade e da depressão a longo prazo. Conclusões: o tempo até a primeira rehospitalização cardiovascular foi de 502 (469-535) dias no grupo de intervenção, comparado com 445 (400-491) dias no grupo de controle. Na avaliação da adesão à medicação, 94 % dos participantes registaram melhorias. Em termos de estratificação do risco cardiovascular, tanto o grupo de intervenção (26 %) como o grupo de controle (6 %) passaram para uma classe de risco inferior.

Associations of the consumption of unprocessed red meat and processed meat with the incidence of cardiovascular disease and mortality, and the dose-response relationship: A systematic review and meta-analysis of cohort studies.

OBJECTIVES: The aim of this study was to examine the associations of unprocessed red meat and processed meat consumption with cardiovascular disease (CVD) incidence and mortality, and the dose-response relationship. METHODS: Published literature was retrieved through a structured search of 10 electronic databases: MEDLINE/PubMed, Scopus, SciELO, LILACS, ScienceDirect, Web of Science, Cochrane (CENTRAL), WHOLIS, PAHO and Embase, without language or year of publication restrictions. In addition, we searched the references of published studies. This systematic review was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyzes: The PRISMA Statement. RESULTS: Twenty-one prospective cohort studies were included in the systematic review. The CVDs evaluated in the inserted studies were stroke, heart failure (HF) and coronary heart disease (CHD). Considering the heterogeneity found in the studies, for the meta-analysis, 9 articles were included. The results presented in the meta-analysis of the association of consumption of unprocessed red meat and CVD indicated that there was a significant association with total stroke incidence (RR 1.10; 95%; CI 1.01 to 1.19; p = 0.02). There was no association with Ischemic stroke incidence, nor CHD Mortality with consumption of unprocessed red meat. However, for Hemorrhagic Stroke Mortality the assessment in the consumption of unprocessed red meat showed an association of protection for women (RR 0.64; 95%; CI 0.45 to 0.91; p = 0.01). As for the results of the meta-analysis of the association between consumption of processed meat and CVD, they indicated that there was a significant association with total stroke incidence (RR 1.17; 95%; CI 1.08 to 1.26; p < 0.0001). There was no association with Ischemic stroke, nor with CHD Mortality with consumption of processed meat. Some studies that showed no association of risk, presented a significant linear trend dose response for the association of the consumption of unprocessed red meat (Bernstein et al. 2010; Nagao et al. 2012) or processed meat (Bernstein et al. 2012) and CVD. CONCLUSION: According to the results found in the meta-analysis, the consumption of unprocessed red meat and processed meat are associated with the incidence of stroke, however, no positive association was observed in relation to mortality from CVD. This systematic review and meta-analysis protocol was registered on the PROSPERO (number: CRD42019100914).

Hyperhomocysteinemia as an Independent Risk Factor for Coronary Heart Disease. Comparison with Conventional Risk Factors / Hiper-homocisteinemia como fator de risco independente para doença coronariana: comparação com fatores de risco convencionais

The present study was designed to evaluate the strength of association of raised plasma homocysteine concentration as a risk factor for coronary heart disease independent of conventional risk factor. It was a case control study conducted at Punjab Institute of Cardiology Lahore. A total of 210 subjects aged 25 to 60 years comprising of 105 newly admitted patients of CHD as cases and 105 age and sex matched healthy individuals with no history of CHD as control were recruited for the study. Fasting blood samples were obtained from cases and controls. Plasma homocysteine was analyzed by fluorescence polarization immunoassay (FPIA) method on automated immunoassay analyzer (Abbott IMX). Total cholesterol, triglyceride and HDL cholesterol were analyzed using calorimetric kit methods. The concentration of LDL cholesterol was calculated using Friedewald formula. The patients were also assessed for traditional risk factors such as age, sex, family history of CVD, hypertension, smoking and physical activity, and were compared with control subjects. The collected data was entered in SPSS version 24 for analysis and interpretation.The mean age in controls and experimental groups were 43.00± 8.42 years and 44.72± 8.59 years with statistically same distribution (p- value= 0.144). The mean plasma homocysteine for cases was 22.33± 9.22 µmol/L where as it was 12.59±3.73 µmol/L in control group. Highly significant difference was seen between the mean plasma level of homocysteine in cases and controls (p˂0.001).Simple logistic regression indicates a strong association of coronary heart disease with hyperhomocysteinemia (OR 7.45), which remained significantly associated with coronary heart disease by multivariate logistic regression (OR 7.10, 95%C1 3.12-12.83, p=0.000). The present study concludes that elevated levels of Plasma homocysteine is an independent risk factor [...].(AU)

O presente estudo foi desenhado para avaliar a força da associação da concentração elevada de homocisteína no plasma como um fator de risco para doença cardíaca coronária independente do fator de risco convencional. Foi um estudo de caso-controle realizado no Punjab Institute of Cardiology Lahore. Um total de 210 indivíduos com idade entre 25 e 60 anos, compreendendo 105 pacientes recém-admitidos de CHD como casos e 105 indivíduos saudáveis pareados por idade e sexo sem histórico de CHD como controle, foi recrutado para o estudo. Amostras de sangue em jejum foram obtidas de casos e controles. A homocisteína plasmática foi analisada pelo método de imunoensaio de polarização de fluorescência (FPIA) em analisador de imunoensaio automatizado (Abbott IMX). Colesterol total, triglicerídeos e colesterol HDL foram analisados usando métodos de kit calorimétrico. A concentração de colesterol LDL foi calculada pela fórmula de Friedewald. Os pacientes também foram avaliados para fatores de risco tradicionais, como idade, sexo, história familiar de DCV, hipertensão, tabagismo e atividade física, e foram comparados com indivíduos de controle. Os dados coletados foram inseridos no SPSS versão 24 para análise e interpretação. A média de idade nos grupos controles e experimentais foi de 43,00 ± 8,42 anos e 44,72 ± 8,59 anos com distribuição estatisticamente igual (p-valor = 0,144). A homocisteína plasmática média para os casos foi de 22,33 ± 9,22 µmol / L, enquanto no grupo controle foi de 12,59 ± 3,73 µmol / L. Diferença altamente significativa foi observada entre o nível plasmático médio de homocisteína em casos e controles (p ˂ 0,001). A regressão logística simples indica uma forte associação de doença cardíaca coronária com hiper-homocisteinemia (OR 7,45), que permaneceu significativamente associada com doença cardíaca coronária por multivariada regressão logística (OR 7,10, 95% C1 3,12-12,83, p = 0,000). O presente estudo conclui [...].(AU)

Hyperhomocysteinemia as an Independent Risk Factor for Coronary Heart Disease. Comparison with Conventional Risk Factors / Hiper-homocisteinemia como fator de risco independente para doença coronariana: comparação com fatores de risco convencionais

Abstract The present study was designed to evaluate the strength of association of raised plasma homocysteine concentration as a risk factor for coronary heart disease independent of conventional risk factor. It was a case control study conducted at Punjab Institute of Cardiology Lahore. A total of 210 subjects aged 25 to 60 years comprising of 105 newly admitted patients of CHD as cases and 105 age and sex matched healthy individuals with no history of CHD as control were recruited for the study. Fasting blood samples were obtained from cases and controls. Plasma homocysteine was analyzed by fluorescence polarization immunoassay (FPIA) method on automated immunoassay analyzer (Abbott IMX). Total cholesterol, triglyceride and HDL cholesterol were analyzed using calorimetric kit methods. The concentration of LDL cholesterol was calculated using Friedewald formula. The patients were also assessed for traditional risk factors such as age, sex, family history of CVD, hypertension, smoking and physical activity, and were compared with control subjects. The collected data was entered in SPSS version 24 for analysis and interpretation.The mean age in controls and experimental groups were 43.00± 8.42 years and 44.72± 8.59 years with statistically same distribution (p- value= 0.144). The mean plasma homocysteine for cases was 22.33± 9.22 µmol/L where as it was 12.59±3.73 µmol/L in control group. Highly significant difference was seen between the mean plasma level of homocysteine in cases and controls (p˂0.001).Simple logistic regression indicates a strong association of coronary heart disease with hyperhomocysteinemia (OR 7.45), which remained significantly associated with coronary heart disease by multivariate logistic regression (OR 7.10, 95%C1 3.12-12.83, p=0.000). The present study concludes that elevated levels of Plasma homocysteine is an independent risk factor for coronary heart disease independent of conventional risk factors and can be used as an indicator for predicting the future possibility for the onset of CVD.

Resumo O presente estudo foi desenhado para avaliar a força da associação da concentração elevada de homocisteína no plasma como um fator de risco para doença cardíaca coronária independente do fator de risco convencional. Foi um estudo de caso-controle realizado no Punjab Institute of Cardiology Lahore. Um total de 210 indivíduos com idade entre 25 e 60 anos, compreendendo 105 pacientes recém-admitidos de CHD como casos e 105 indivíduos saudáveis ​​pareados por idade e sexo sem histórico de CHD como controle, foi recrutado para o estudo. Amostras de sangue em jejum foram obtidas de casos e controles. A homocisteína plasmática foi analisada pelo método de imunoensaio de polarização de fluorescência (FPIA) em analisador de imunoensaio automatizado (Abbott IMX). Colesterol total, triglicerídeos e colesterol HDL foram analisados ​​usando métodos de kit calorimétrico. A concentração de colesterol LDL foi calculada pela fórmula de Friedewald. Os pacientes também foram avaliados para fatores de risco tradicionais, como idade, sexo, história familiar de DCV, hipertensão, tabagismo e atividade física, e foram comparados com indivíduos de controle. Os dados coletados foram inseridos no SPSS versão 24 para análise e interpretação. A média de idade nos grupos controles e experimentais foi de 43,00 ± 8,42 anos e 44,72 ± 8,59 anos com distribuição estatisticamente igual (p-valor = 0,144). A homocisteína plasmática média para os casos foi de 22,33 ± 9,22 µmol / L, enquanto no grupo controle foi de 12,59 ± 3,73 µmol / L. Diferença altamente significativa foi observada entre o nível plasmático médio de homocisteína em casos e controles (p ˂ 0,001). A regressão logística simples indica uma forte associação de doença cardíaca coronária com hiper-homocisteinemia (OR 7,45), que permaneceu significativamente associada com doença cardíaca coronária por multivariada regressão logística (OR 7,10, 95% C1 3,12-12,83, p = 0,000). O presente estudo conclui que níveis elevados de homocisteína plasmática são fator de risco independente para doença cardíaca coronária, independentemente dos fatores de risco convencionais, e pode ser usado como um indicador para prever a possibilidade futura de aparecimento de DCV.